Chu Chi D, Powe Neil R, Crews Deidra C, Tuot Delphine S
Department of Medicine, University of California-San Francisco, San Francisco, California; OptumLabs, Eden Prairie, Minnesota.
Department of Medicine, University of California-San Francisco, San Francisco, California; Center for Vulnerable Populations, University of California-San Francisco, San Francisco, California; Department of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, California.
Am J Kidney Dis. 2022 Jun;79(6):841-848.e1. doi: 10.1053/j.ajkd.2021.08.010. Epub 2021 Sep 17.
RATIONALE & OBJECTIVE: Equations for estimated glomerular filtration rate (eGFR) that incorporate a term for race assign a higher value to Black individuals compared to non-Black individuals for the same sex, age, and serum creatinine concentration. This difference may contribute to racial disparities in kidney transplant access. We sought to (1) compare time from meeting a transplant eligibility threshold of eGFR ≤20 mL/min/1.73 m to kidney failure with replacement therapy (KFRT) among Black, Hispanic, and White patients, and (2) assess the impact of incorporation of race into eGFR expressions on establishment of waitlist eligibility and time from eligibility to KFRT.
Retrospective cohort.
SETTING & PARTICIPANTS: Using the OptumLabs Data Warehouse, we assembled a cohort of 40,042 White, 8,519 Black, and 3,569 Hispanic patients having at least one eGFR value between 20 and 60 mL/min/1.73 m within the preceding 2 years and an incident outpatient eGFR of ≤20 mL/min/1.73 m between 2008-2018, using the CKD-EPI creatinine equation that includes a term for race coded as Black or non-Black. We then reassembled a Black patient cohort based on incident eGFR ≤20 mL/min/1.73 m (n = 11,269) estimated using the same CKD-EPI equation but coding Black patients as non-Black.
Race/ethnicity.
Time to KFRT.
Unadjusted and adjusted Fine-Gray models; linear regression to compute eGFR slopes.
By 3 years, the cumulative incidence of KFRT was 20.5% among White patients, 40.9% among Hispanic patients, 36% among Black patients whose GFR was estimated using a race term coded as Black, and 28.7% among Black patients whose GFR was estimated using a race term coded as non-Black. In fully adjusted analyses including 11,269 Black patients with an eGFR ≤20 mL/min/1.73 m based on coding them as non-Black, KFRT risk remained greater among Black (HR, 1.28 [95% CI, 1.15-1.43]) and Hispanic (HR, 1.66 [95% CI, 1.18-2.31]) patients than among White patients. Based on slopes of eGFR decline, coding Black patients as non-Black would allow earlier waitlist activation by an estimated median of 0.5 [interquartile range, 0.27-1.23] years.
Inability to exclude individuals who would not be kidney transplant candidates if comprehensively evaluated.
A uniform eGFR threshold provides less opportunity for being placed on the transplant waitlist among Black and Hispanic patients. For many Black patients, estimation of GFR as if their race category were non-Black would allow substantially earlier waitlisting but would not eliminate their shorter time to KFRT and reduced opportunity for preemptive transplantation compared with White patients.
估算肾小球滤过率(eGFR)的公式中纳入了种族因素,对于相同性别、年龄和血清肌酐浓度的个体,黑人个体的eGFR值比非黑人个体更高。这种差异可能导致肾移植机会方面的种族差异。我们旨在:(1)比较黑人、西班牙裔和白人患者从达到eGFR≤20 mL/min/1.73 m的移植资格阈值到进入肾衰竭并接受替代治疗(KFRT)的时间;(2)评估在eGFR表达式中纳入种族因素对确定等待名单资格以及从资格确定到KFRT的时间的影响。
回顾性队列研究。
利用OptumLabs数据仓库,我们纳入了一组队列,其中有40,042名白人、8,519名黑人以及3,569名西班牙裔患者,这些患者在过去2年内至少有一个eGFR值在20至60 mL/min/1.73 m之间,并且在2008 - 2018年间门诊eGFR初值≤20 mL/min/1.73 m,使用的是CKD - EPI肌酐公式,该公式纳入了一个种族因素项,将种族编码为黑人或非黑人。然后,我们根据使用相同CKD - EPI公式但将黑人患者编码为非黑人来估算的初发eGFR≤20 mL/min/1.73 m,重新组建了一个黑人患者队列(n = 11,269)。
种族/族裔。
至KFRT的时间。
未调整和调整后的Fine - Gray模型;采用线性回归计算eGFR斜率。
到3年时,白人患者中KFRT的累积发生率为为20.5%,西班牙裔患者中为40.9%,使用种族因素项编码为黑人估算GFR的黑人患者中为36%,而使用种族因素项编码为非黑人估算GFR的黑人患者中为28.7%。在对11,269名基于编码为非黑人而eGFR≤20 mL/min/1.73 m的黑人患者进行的完全调整分析中,黑人(风险比[HR],1.28 [95%置信区间(CI),1.15 - 1.43])和西班牙裔(HR,1.66 [95% CI,1.18 - 2.31])患者发生KFRT的风险仍高于白人患者。根据eGFR下降斜率,将黑人患者编码为非黑人会使等待名单激活时间提前,估计中位数为0.5年[四分位间距,0.27 - 1.23年]。
无法排除如果进行全面评估就不会成为肾移植候选者的个体。
统一的eGFR阈值使黑人和西班牙裔患者进入移植等待名单的机会减少。对于许多黑人患者,将其种族类别视为非黑人来估算GFR会使他们能更早进入等待名单,但与白人患者相比,这并不能消除他们至KFRT的时间更短以及抢先移植机会减少的情况。